Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 27.83% is in line with its 5-year average of 29.99%, near the low end of its 5-year range (26.04%–37.34%).
As of the fiscal period ended Tuesday, June 30, 2026. 1.56% below its 12-month average of 28.27%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 27.83%.
DEBT TO ASSETS RATIO
27.83%
DEBT TO ASSETS RATIO AVG TTM
28.27%
DEBT TO ASSETS RATIO AVG 3Y
29.57%
DEBT TO ASSETS RATIO AVG 5Y
29.99%
DEBT TO ASSETS RATIO AVG 10Y
30.37%
DEBT TO ASSETS RATIO AVG 15Y
26.88%
DEBT TO ASSETS RATIO AVG 20Y
24.89%
CURRENT VS TTM AVG
-1.56%
CURRENT VS 3Y AVG
-5.88%
CURRENT VS 5Y AVG
-7.20%
CURRENT VS 10Y AVG
-8.36%
CURRENT VS 15Y AVG
+3.53%
CURRENT VS 20Y AVG
+11.81%
SECTOR MEDIAN · HEALTHCARE
0.29%
median of 90 covered companies
CURRENT VS SECTOR MEDIAN
+9665.72%
vs the sector median at left
AstraZeneca PLC
Market Cap
$248.40B
Debt to Assets Ratio
27.83%
TTM Avg
28.27%
3Y Avg
29.57%
5Y Avg
29.99%
Market Cap
$226.62B
Debt to Assets Ratio
0.38%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$178.44B
Debt to Assets Ratio
0.53%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$344.27B
Debt to Assets Ratio
0.24%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| AstraZeneca PLC (AZN) | $248.40B | 27.83% | 28.27% | 29.57% | 29.99% |
| Thermo Fisher Scientific Inc. (TMO)vs › | $226.62B | 0.38% | N/A | N/A | N/A |
| Amgen Inc. (AMGN)vs › | $203.66B | 0.60% | N/A | N/A | N/A |
| Novo Nordisk A/S (NVO)vs › | $191.26B | 0.24% | N/A | N/A | N/A |
| Gilead Sciences, Inc. (GILD)vs › | $178.44B | 0.53% | N/A | N/A | N/A |
| Abbott Laboratories (ABT)vs › | $176.43B | 0.30% | N/A | N/A | N/A |
| Roche Holding AG (RHHBY)vs › | $336.71B | 0.32% | N/A | N/A | N/A |
| Pfizer Inc. (PFE)vs › | $157.99B | 0.31% | N/A | N/A | N/A |
| UnitedHealth Group Incorporated (UNH)vs › | $344.27B | 0.24% | N/A | N/A | N/A |
| Merck & Co., Inc. (MRK)vs › | $355.49B | 0.42% | N/A | N/A | N/A |
Debt/Assets
27.8%
Debt/Equity
0.64
Current Ratio
0.89
Interest Coverage
8.1x
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 27.83% |
| 2026-03-31 | 29.75% |
| 2025-12-31 | 26.04% |
| 2025-09-30 | 28.54% |
| 2025-06-30 | 29.21% |
| 2025-03-30 | 29.85% |
| 2024-12-31 | 28.95% |
| 2024-09-30 | 30.08% |
| 2024-06-30 | 32.14% |
| 2024-03-31 | 33.78% |
| 2023-12-31 | 28.31% |
| 2023-09-30 | 29.74% |
| 2023-06-30 | 30.91% |
| 2023-03-31 | 32.58% |
| 2022-12-31 | 30.30% |
| 2022-09-30 | 31.11% |
| 2022-06-30 | 30.57% |
| 2022-03-31 | 31.01% |
| 2021-12-31 | 29.21% |
| 2021-09-30 | 29.76% |
| 2021-06-30 | 37.34% |
| 2021-03-31 | 31.01% |
| 2020-12-31 | 30.54% |
| 2020-09-30 | 34.84% |
| 2020-06-30 | 32.95% |
| 2020-03-31 | 32.47% |
| 2019-12-31 | 29.70% |
| 2019-09-30 | 30.83% |
| 2019-06-30 | 31.84% |
| 2019-03-31 | 35.34% |
| 2018-12-31 | 31.51% |
| 2018-09-30 | 34.04% |
| 2018-06-30 | 32.06% |
| 2018-03-31 | 31.37% |
| 2017-12-31 | 28.11% |
| 2017-09-30 | 27.64% |
| 2017-06-30 | 30.29% |
| 2017-03-31 | 28.55% |
| 2016-12-31 | 26.88% |
| 2016-09-30 | 27.97% |
| 2016-06-30 | 27.29% |
| 2016-03-31 | 25.36% |
| 2015-12-31 | 25.04% |
| 2015-09-30 | 20.23% |
| 2015-06-30 | 19.95% |
| 2015-03-31 | 19.68% |
| 2014-12-31 | 18.50% |
| 2014-09-30 | 17.67% |
| 2014-06-30 | 17.21% |
| 2014-03-31 | 17.41% |
| 2013-12-31 | 18.56% |
| 2013-09-30 | 18.99% |
| 2013-06-30 | 19.24% |
| 2013-03-31 | 19.51% |
| 2012-12-31 | 19.26% |
| 2012-09-30 | 20.81% |
| 2012-06-30 | 18.13% |
| 2012-03-31 | 18.48% |
| 2011-12-31 | 17.66% |
| 2011-09-30 | 17.97% |
| 2011-06-30 | 17.94% |
| 2011-03-31 | 18.27% |
| 2010-12-31 | 16.43% |
| 2010-09-30 | 19.34% |
| 2010-06-30 | 2.73% |
| 2010-03-31 | 19.54% |
| 2009-12-31 | 3.95% |
| 2009-09-30 | 22.17% |
| 2009-06-30 | 23.55% |
| 2009-03-31 | 25.30% |
| 2008-12-31 | 25.32% |
| 2008-09-30 | 27.74% |
| 2008-06-30 | 29.63% |
| 2008-03-31 | 30.96% |
| 2007-12-31 | 31.60% |
| 2007-09-30 | 31.33% |
| 2007-06-30 | 32.35% |
| 2007-03-31 | 3.88% |
| 2006-12-31 | 4.09% |
| 2006-09-30 | 4.27% |
| 2006-06-30 | 3.97% |
| 2006-03-31 | 4.09% |
| 2005-12-31 | 4.83% |
| 2005-09-30 | 5.07% |
| 2005-06-30 | 5.28% |
| 2005-03-31 | 4.83% |
| 2004-12-31 | 4.58% |
| 2004-09-30 | 5.17% |
| 2004-06-30 | 4.93% |
| 2004-03-31 | 1.59% |
| 2003-12-31 | 1.93% |
| 2003-09-30 | 0.00% |
| 2003-06-30 | 1.71% |
| 2003-03-31 | 0.00% |
| 2002-12-31 | 3.91% |
| 2002-09-30 | 0.00% |
